News from omthera pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 16, 2013, 12:00 ET
Omthera Pharmaceuticals, Inc. Logo.  (PRNewsFoto/Omthera Pharmaceuticals, Inc.)

Omthera Stockholders Approve Acquisition by AstraZeneca

The stockholders of Omthera Pharmaceuticals, Inc. (NASDAQ: OMTH) (the "Company") voted today at a special meeting of stockholders to adopt the...

Jul 11, 2013, 09:00 ET

Omthera Announces Waiver of Lock-Up Restriction

 Omthera Pharmaceuticals, Inc. (the "Company") announced today that BofA Merrill Lynch and Barclays, the lead book-running managers in the...

Jul 09, 2013, 06:00 ET

Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides

 Omthera Pharmaceuticals, Inc. (Nasdaq: OMTH), an emerging specialty pharmaceutical company, today announced that it has submitted a New Drug...

Jun 27, 2013, 11:00 ET

Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period

 Omthera Pharmaceuticals, Inc. (NASDAQ: OMTH) today announced that, as of June 26, 2013, the Federal Trade Commission granted early termination...

Jun 13, 2013, 12:13 ET

Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders

Omthera Pharmaceuticals, Inc. (NASDAQ: OMTH) today announced that it has established a record date and a meeting date for the special meeting of...

May 28, 2013, 08:30 ET

Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results

Omthera Pharmaceuticals, Inc. (Nasdaq: OMTH), an emerging specialty pharmaceutical company, today announced its financial results for the first...

May 28, 2013, 02:00 ET

AstraZeneca to Acquire Omthera Pharmaceuticals Including NDA-Ready Novel Dyslipidemia Treatment to Complement Cardiovascular Portfolio

AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company...

Apr 16, 2013, 11:30 ET

Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering

Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for...

Apr 11, 2013, 09:20 ET

Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering

 Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies...

Nov 09, 2012, 08:33 ET

Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk

 Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced that Chief Medical Officer, Dr. Michael H....

Nov 05, 2012, 08:32 ET

Omthera Pharmaceuticals Presents Successful Phase 3 Results from EVOLVE and ESPRIT Clinical Studies for Epanova™; Both Trials Meet Primary and Secondary Endpoints

 Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced that Phase 3 results from its EVOLVE...

Nov 02, 2012, 08:04 ET

Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies

Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced an invitation to attend the presentation of data...

Apr 26, 2012, 09:00 ET

Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study

 Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced positive top-line data from its EVOLVE...

Feb 15, 2012, 09:41 ET

Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference

 Omthera Pharmaceuticals, Inc., a privately held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President...

Jan 09, 2012, 09:00 ET

Omthera Pharmaceuticals Announces Positive Long Term Bioavailability Data Comparing Epanova™ to Lovaza®

Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced positive data from a pharmacokinetic study...

Jan 04, 2012, 13:14 ET

Omthera Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief...

Nov 29, 2011, 09:00 ET

Omthera Pharmaceuticals Completes Enrollment of Pivotal Phase III EVOLVE Trial for Epanova™ in Patients With Very High Triglycerides

Omthera Pharmaceuticals, Inc. a privately-held emerging specialty pharmaceuticals company, announced today that it has completed enrollment...

Nov 21, 2011, 09:27 ET

Omthera Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference

 Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler,...

Oct 25, 2011, 10:00 ET

Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Timothy J. Maines has joined the...

Sep 06, 2011, 10:45 ET

Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief...